EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The LGALS9 / miR ‐491‐5p Axis Regulates CD8 + T Cell Function and Inhibits the Progression of Gastric Cancer

Wanzhong Huang iD, Wei Zheng, Dagao Zhu, Zhi Sun, Wei Lu, Jun Tao, Chen Liu, Liangliang Li, Yingli Zhou, Honghong Fan, Hong Tao, Wenjuan Li

Cancer Science · 2026

DOI: 10.1111/cas.70232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2026. Verfasst von Wanzhong Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Tonglin People's Hospital, Tonglin, Anhui, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, MicroRNAs, CD8-Positive T-Lymphocytes, Galectins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Projects of Bengbu Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer is a prevalent and clinically significant gastrointestinal malignancy worldwide. Gastric cancer is characterized by limited treatment efficacy and a high recurrence rate. In this study, we found that LGALS9 was highly expressed in gastric cancer and may contribute to disease progression by modulating the infiltration of CD8 + T cells. Genetic knockout of LGALS9 reversed T cell function, attenuated immunosuppression, and enhanced the cytotoxic activity of T cells to kill gastric cancer cells. Furthermore, miR‐491‐5p was identified as a potential suppressor in gastric cancer. The microRNA miR‐491‐5p regulated T cell‐mediated immunity by targeting and inhibiting LGALS9, which was similar to the effect of LGALS9 knockout. Overall, the key target LGALS9 and its inhibitor miR‐491‐5p represent promising potential for treating gastric cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsMicroRNAsCD8-Positive T-LymphocytesGalectinsHumansDisease ProgressionAnimalsCell Line, TumorMiceGene Expression Regulation, NeoplasticMaleFemale

Stichwörter der Autor:innen

LGALS9T cellgastric cancerimmunosuppressionmiR‐491‐5p

Substanzen

MicroRNAsLGALS9 protein, humanGalectins

Autor:innen und Institutionen

  • Department of Medical Oncology, Tonglin People's Hospital, Tonglin, Anhui, China.
  • Department of Medical Oncology, Tongling Hospital Affiliated to Bengbu Medical University, Tonglin, Anhui, China.
  • Department of Gastrointestinal Surgery, Tonglin People's Hospital, Tonglin, Anhui, China.
  • Department of Gastrointestinal Surgery, Tongling Hospital Affiliated to Bengbu Medical University, Tonglin, Anhui, China.
  • Department of Pathology, Tonglin People's Hospital, Tonglin, Anhui, China.
  • Department of Pathology, Tongling Hospital Affiliated to Bengbu Medical University, Tonglin, Anhui, China.

ORCID-Profile: Wanzhong Huang

Förderung

  • Natural Science Projects of Bengbu Medical College

Zitieren

APA

Huang, W., Zheng, W., Zhu, D., Sun, Z., Lu, W., Tao, J., Liu, C., Li, L., Zhou, Y., Fan, H., Tao, H., & Li, W. (2026). The LGALS9 / miR ‐491‐5p Axis Regulates CD8 + T Cell Function and Inhibits the Progression of Gastric Cancer. Cancer Science. https://doi.org/10.1111/cas.70232

Vancouver

Huang W, Zheng W, Zhu D, Sun Z, Lu W, Tao J, et al. The LGALS9 / miR ‐491‐5p Axis Regulates CD8 + T Cell Function and Inhibits the Progression of Gastric Cancer. Cancer Science. 2026. doi:10.1111/cas.70232

BibTeX
@article{Huang2026,
  author = {Huang, Wanzhong and Zheng, Wei and Zhu, Dagao and Sun, Zhi and Lu, Wei and Tao, Jun and Liu, Chen and Li, Liangliang and Zhou, Yingli and Fan, Honghong and Tao, Hong and Li, Wenjuan},
  title = {The LGALS9 / miR ‐491‐5p Axis Regulates CD8 + T Cell Function and Inhibits the Progression of Gastric Cancer},
  journal = {Cancer Science},
  year = {2026},
  doi = {10.1111/cas.70232}
}
Kostenlos starten →